
RNAC Market Capitalization Overview
Market Cap: $270.45M as of Jun 13, 2025
$270.45M
Past Month-$259.50K (0.10%)
As of Jun 13, 2025, RNAC has a market capitalization of $270.45M. Over the past 30 days, its market cap has decreased by -18.61%, while in the last 12 months, it has decreased by -41.3%.
Market capitalization represents the total value of Cartesian Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
RNAC Market Cap Formula = Stock Price * Shares Outstanding
The market cap of RNAC helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Cartesian Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
RNAC Market Cap Formula = Stock Price * Shares Outstanding
The market cap of RNAC helps investors assess the company's size and compare it with competitors for better investment decisions.
RNAC Market Cap & Key Trends
See Cartesian Therapeutics Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in RNAC
Order type
Buy in
Order amount
Est. shares
0 shares
RNAC Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $259.03M | -18.61% |
May 1, 2025 | $318.25M | -1.65% |
Apr 1, 2025 | $323.58M | -28.12% |
Mar 3, 2025 | $450.20M | -12.02% |
Feb 3, 2025 | $511.68M | +17.48% |
Jan 2, 2025 | $435.53M | -12.43% |
RNAC End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $270.45M | -41.30% |
2024 | $460.75M | +331.58% |
2023 | $106.76M | +23.47% |
2022 | $86.47M | -57.09% |
2021 | $201.51M | +23.07% |
2020 | $163.73M | — |
FAQs About Cartesian Therapeutics Inc (RNAC) Market Cap
As of Jun 13, 2025, the market capitalization of RNAC is $270.45M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Cartesian Therapeutics Inc’s market capitalization has decreased by -0.1000%, changing from $270.71M to $270.45M as of Jun 13, 2025.
In the last 3 months, Cartesian Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Cartesian Therapeutics Inc’s market capitalization increased from $106.76M in January to $460.75M in December, reflecting a 331.58% change.
In the past five years, RNAC has had a compound annual growth rate (CAGR) of 22.99% in market capitalization. This means its market cap has grown at an average rate of 22.99% per year.